Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation.

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Harumi Katoh, Toshio Shimada, Shin-Ichi Inoue, Nobuyuki Takahashi, Hiromi Shimizu, Yoko Ohta, Ko Nakamura, Yo Murakami, Yutaka Ishibashi, Akira Matsumori
{"title":"Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation.","authors":"Harumi Katoh,&nbsp;Toshio Shimada,&nbsp;Shin-Ichi Inoue,&nbsp;Nobuyuki Takahashi,&nbsp;Hiromi Shimizu,&nbsp;Yoko Ohta,&nbsp;Ko Nakamura,&nbsp;Yo Murakami,&nbsp;Yutaka Ishibashi,&nbsp;Akira Matsumori","doi":"10.1111/j.1440-1681.2004.03970.x","DOIUrl":null,"url":null,"abstract":"<p><p>1. Serum hepatocyte growth factor (HGF) is considered to be a potent marker of vascular endothelial injury. The present study was designed to examine serum HGF levels in atrial fibrillation and after successful direct current (DC) cardioversion. 2. We measured serum HGF levels before and 7 days and 1 month after DC cardioversion in 39 patients with atrial fibrillation in whom sinus rhythm was maintained for at least 7 days after DC cardioversion and in 30 age- and sex-matched normal control subjects with sinus rhythm. We also measured acetylcholine-induced changes in forearm blood flow (FBF) using venous occlusive plethysmography in 10 patients. 3. Serum HGF levels were significantly higher in the atrial fibrillation patients (both lone atrial fibrillation and with underlying heart disease) than in the controls (0.16 +/- 0.07 vs 0.10 +/- 0.04 ng/mL; P < 0.001). Seven days after successful DC cardioversion, the patients' serum HGF levels had decreased significantly (0.16 +/- 0.07 vs 0.12 +/- 0.06 ng/mL; P < 0.05) and in the 24 patients maintaining sinus rhythm 1 month after DC cardioversion, serum HGF levels decreased to control values (0.10 +/- 0.08 ng/mL at 1 month). Serum HGF levels of the 15 patients who had relapsed into atrial fibrillation 1 month after DC cardioversion tended to decrease 7 days after DC cardioversion, but increased again 1 month after DC cardioversion. Percentage changes in FBF between baseline and the highest dose of acetylcholine before and after DC cardioversion were 180 +/- 98 and 323 +/- 196%, respectively (P = 0.0051). The rate of increase in FBF at the highest dose of acetylcholine between before and after DC cardioversion correlated negatively with the rate of decrease in serum HGF levels between before and after DC cardioversion (r = -0.837; P = 0.0025). 4. This study is the first to demonstrate that serum HGF levels increase in atrial fibrillation and decrease after successful DC cardioversion. This may reflect the fact that atrial fibrillation induces vascular endothelial injury.</p>","PeriodicalId":10259,"journal":{"name":"Clinical and Experimental Pharmacology and Physiology","volume":"31 3","pages":"145-51"},"PeriodicalIF":2.4000,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1440-1681.2004.03970.x","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Pharmacology and Physiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1440-1681.2004.03970.x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 9

Abstract

1. Serum hepatocyte growth factor (HGF) is considered to be a potent marker of vascular endothelial injury. The present study was designed to examine serum HGF levels in atrial fibrillation and after successful direct current (DC) cardioversion. 2. We measured serum HGF levels before and 7 days and 1 month after DC cardioversion in 39 patients with atrial fibrillation in whom sinus rhythm was maintained for at least 7 days after DC cardioversion and in 30 age- and sex-matched normal control subjects with sinus rhythm. We also measured acetylcholine-induced changes in forearm blood flow (FBF) using venous occlusive plethysmography in 10 patients. 3. Serum HGF levels were significantly higher in the atrial fibrillation patients (both lone atrial fibrillation and with underlying heart disease) than in the controls (0.16 +/- 0.07 vs 0.10 +/- 0.04 ng/mL; P < 0.001). Seven days after successful DC cardioversion, the patients' serum HGF levels had decreased significantly (0.16 +/- 0.07 vs 0.12 +/- 0.06 ng/mL; P < 0.05) and in the 24 patients maintaining sinus rhythm 1 month after DC cardioversion, serum HGF levels decreased to control values (0.10 +/- 0.08 ng/mL at 1 month). Serum HGF levels of the 15 patients who had relapsed into atrial fibrillation 1 month after DC cardioversion tended to decrease 7 days after DC cardioversion, but increased again 1 month after DC cardioversion. Percentage changes in FBF between baseline and the highest dose of acetylcholine before and after DC cardioversion were 180 +/- 98 and 323 +/- 196%, respectively (P = 0.0051). The rate of increase in FBF at the highest dose of acetylcholine between before and after DC cardioversion correlated negatively with the rate of decrease in serum HGF levels between before and after DC cardioversion (r = -0.837; P = 0.0025). 4. This study is the first to demonstrate that serum HGF levels increase in atrial fibrillation and decrease after successful DC cardioversion. This may reflect the fact that atrial fibrillation induces vascular endothelial injury.

降低房颤患者心律转复成功后高血清肝细胞生长因子水平。
1. 血清肝细胞生长因子(HGF)被认为是血管内皮损伤的有效标志。本研究旨在检测心房颤动和成功的直流电(DC)转复后的血清HGF水平。2. 我们测量了39例房颤患者的血清HGF水平,这些患者在房颤复律后至少维持7天的窦性心律,以及30例年龄和性别匹配的正常对照组的窦性心律。我们还测量了10例患者的静脉闭塞性容积描记术中乙酰胆碱引起的前臂血流量(FBF)变化。3.房颤患者(单发房颤和伴有潜在心脏病的房颤)血清HGF水平显著高于对照组(0.16 +/- 0.07 vs 0.10 +/- 0.04 ng/mL;P < 0.001)。DC转复成功后7天,患者血清HGF水平显著降低(0.16 +/- 0.07 vs 0.12 +/- 0.06 ng/mL;P < 0.05),在24例维持窦性心律1个月的患者中,血清HGF水平下降到控制值(1个月时0.10 +/- 0.08 ng/mL)。15例房颤复发患者在DC复心1个月后血清HGF水平在DC复心7天后呈下降趋势,但在DC复心1个月后再次升高。DC复律前后基线与最高剂量乙酰胆碱的FBF变化百分比分别为180 +/- 98%和323 +/- 196% (P = 0.0051)。最高剂量乙酰胆碱治疗后DC复律前后FBF升高率与DC复律前后血清HGF下降率呈负相关(r = -0.837;P = 0.0025)。4. 本研究首次证实房颤患者血清HGF水平升高,DC转复成功后降低。这可能反映了心房颤动引起血管内皮损伤的事实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Experimental Pharmacology and Physiology
Clinical and Experimental Pharmacology and Physiology PHARMACOLOGY & PHARMACY-PHYSIOLOGY
自引率
0.00%
发文量
128
期刊介绍: Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信